PHARMACOKINETICS OF THE PROTON PUMP INHIBITOR PANTOPRAZOLE IN PATIENTS WITH SEVERE RENAL IMPAIRMENT

被引:0
|
作者
LINS, RL
DECLERCQ, I
HARTMANN, M
HUBER, R
BLIESATH, H
LUHMANN, R
WURST, W
机构
[1] AZ STUIVENBURG,RES UNIT,ANTWERP,BELGIUM
[2] BYK GULDEN LOMBERG GMBH,CONSTANCE,GERMANY
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A126 / A126
页数:1
相关论文
共 50 条
  • [41] Pantoprazole, a new proton-pump inhibitor, has a precise and predictable profile of activity
    Parsons, ME
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1996, 8 : S15 - S20
  • [42] Influence of pantoprazole, a proton-pump inhibitor, on serum calcium and phosphate levels in rats
    Matuszewska, Agnieszka
    Nowak, Beata
    Merwid-Lad, Anna
    Szandruk, Marta
    Kwiatkowska, Joanna
    Piesniewska, Malgorzata
    Szelag, Adam
    PHARMACOLOGICAL REPORTS, 2015, 67 : 29 - 29
  • [43] Population Pharmacokinetics of Edoxaban in Japanese Atrial Fibrillation Patients With Severe Renal Impairment
    Shimizu, Takako
    Tachibana, Masaya
    Kimura, Tetsuya
    Kumakura, Tomohiko
    Yoshihara, Kazutaka
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2017, 6 (05): : 484 - 491
  • [44] Pantoprazole, a proton-pump inhibitor, impairs human sperm motility and capacitation in vitro
    Escoffier, Jessica
    Arnaud, Bastien
    Kaba, Mayis
    Hograindleur, Jean Pascal
    Le Blevec, Emilie
    Martinez, Guillaume
    Stevant, Isabelle
    Ray, Pierre F.
    Arnoult, Christophe
    Nef, Serge
    ANDROLOGY, 2020, 8 (06) : 1795 - 1804
  • [45] Mechanisms by which pantoprazole, a proton pump inhibitor, enhances the activity of doxorubicin in solid tumors
    Tan, Qian
    Patel, Krupa
    Lee, Carol M.
    Zhang, Junyan
    Joshua, Anthony
    Koritzinsky, Marianne
    Wouters, Bradly G.
    Tannock, Ian F.
    CANCER RESEARCH, 2011, 71
  • [46] Pharmacokinetics and Bioequivalence Study of Two Proton Pump Inhibitor Products
    Taha, Ehab Ibrahim
    Abd-Alla, Fathy Ibrahim
    BRITISH JOURNAL OF PHARMACEUTICAL RESEARCH, 2016, 13 (06):
  • [47] A CASE OF SEVERE HYPOMAGNESEMIA RELATED TO PROTON PUMP INHIBITOR
    Abu-Hashish, Hussein
    Askar, Esraa
    Cherazard, Regine
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2023, 38 : S382 - S382
  • [48] Influence of the proton pump inhibitor omeprazole on the pharmacokinetics of the HCV protease inhibitor boceprevir
    de Kanter, Clara
    Colbers, Angela
    Roukens, Monique
    Blonk, Maren
    Schouwenberg, Bas
    Drenth, Joost
    Burger, David M.
    HEPATOLOGY, 2012, 56 : 1035A - 1035A
  • [49] Proton Pump Inhibitor Use and the Risk of Declining Renal Function in Patients with Diabetes
    Hayashino, Yasuaki
    Okamura, Shintaro
    Tsujii, Satoru
    Ishii, Hitoshi
    DIABETES, 2017, 66 : A451 - A451
  • [50] The Effect of Proton Pump Inhibitor Use on Renal Function in Kidney Transplanted Patients
    Flothow, Dominik J. G.
    Suwelack, Barbara
    Pavenstaedt, Hermann
    Schuette-Nuetgen, Katharina
    Reuter, Stefan
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (01)